5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with camptothecin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Hamada, N; Ikari, A; Kakinoki, B; Sakai, H; Sato, T; Takeguchi, N; Yasue, M | 1 |
3 other study(ies) available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and camptothecin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzimidazoles; Benzoxepins; Camptothecin; Carbachol; Chloride Channels; Chlorides; Colon; Cyclooxygenase Inhibitors; Dinoprostone; Female; Imidazoles; Indomethacin; Intestinal Mucosa; Irinotecan; Membrane Potentials; Nitrobenzoates; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, Thromboxane; Tetrodotoxin; Thromboxane A2; Thromboxane-A Synthase | 1997 |